AB

Anant Bhausaheb Kahandal

Active Director Director DIN 10454787
DIN 10454787 First appointment Jan 2024 Primary industry Machinery and Equipment
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Anant Bhausaheb Kahandal

Data last updated:

Anant Bhausaheb Kahandal is a Director at Dianta Pharmtech Private Limited (since 2024). The company operates in Machinery and Equipment.

DIN 10454787
Primary Designation Director
Industry Machinery and Equipment
First Appointment 05 Jan 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dianta Pharmtech Private Limited U32500MH2024PTC416790
Director05 Jan 20242024Active

Board colleagues of Anant Bhausaheb Kahandal

NameDINCompanyDesignation
Anuja Digambar Pawar07747563Dianta Pharmtech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dianta Pharmtech Private Limited
Premium access

Shareholding and investment profile for Anant Bhausaheb Kahandal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anant Bhausaheb Kahandal

Anant Bhausaheb Kahandal currently holds 1 directorship: Dianta Pharmtech Private Limited (Director, since 05 Jan 2024).

Anant Bhausaheb Kahandal was first appointed on 05 Jan 2024 as Director at Dianta Pharmtech Private Limited.

The current boards of Anant Bhausaheb Kahandal's companies include Anuja Digambar Pawar (Dianta Pharmtech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available